Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04643431
Other study ID # IRB #20D.699
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received
Last updated
Start date December 1, 2020
Est. completion date May 1, 2024

Study information

Verified date March 2024
Source Thomas Jefferson University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an open-label, non-randomized study conducted at Thomas Jefferson University comparing pressure-gradient estimates (obtained between a carotid plaque and the carotid artery) to imaging and histology markers of plaque vulnerability. There is an inverse relationship between the subharmonic signal magnitude from contrast-enhanced ultrasound microbubbles and ambient pressure. This pressure estimation technique (referred as SHAPE) will be used to estimate the pressure gradient across the carotid plaque cap noninvasively in vivo.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date May 1, 2024
Est. primary completion date April 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients >18 years old and willing and able to participate. Patients with atherosclerosis scheduled for carotid endarterectomy Exclusion Criteria: - • Pregnancy or breast-feeding at the time of the scan - Patients with known hypersensitivity or allergy to any component (including perflutren) of Definity (Lantheus Medical Imaging, Billerica, MA). - Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example: - Patients on life support or in a critical care unit. - Patients with unstable occlusive disease (e.g., crescendo angina). - Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia. - Patients with uncontrolled congestive heart failure (NYHA Class IV). - Patients with recent cerebral hemorrhage. - Patients who have undergone surgery within 24 hours prior to the study sonographic examination. - Patients with unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias) or respiratory distress syndrome. - Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli. - Patients who have received any contrast medium (X-ray, MRI, CT or ultrasound) in the 24 hours prior to the research ultrasound exam

Study Design


Intervention

Diagnostic Test:
Perflutren
The ultrasound contrast agent is used to improve the quality of ultrasound imaging and is infused over 5-10 minutes. The contrast agent consists of the gas-filled microbubbles smaller than the capillary size which circulate in the vascular system. The contrast agent is cleared from the body naturally within 30 minutes.

Locations

Country Name City State
United States Thomas jefferson University Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Thomas Jefferson University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between the pressure gradient and surrogate (imaging and histological) predictors The estimates of pressure-gradient across the plaque cap from 3D SHAPE technique will be compared with the surrogate imaging and histological predictors using Pearson's correlation coefficient. The correlations between the surrogate predictors will be also calculated using Pearson's correlation coefficient. We expect the pressure-gradient estimates from SHAPE technique is moderately correlated (above 0.5) with the surrogate predictors. pre-endarterectomy
See also
  Status Clinical Trial Phase
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Withdrawn NCT03630835 - 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques Phase 2/Phase 3
Completed NCT02722720 - Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral N/A
Completed NCT01893489 - Visualization of Carotid Atherosclerosis by 68Ga-MSA Phase 1
Withdrawn NCT00861159 - RLIP76 in Human Serum in Adults With Rheumatologic Diseases N/A
Recruiting NCT01743404 - Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis Phase 2
Completed NCT00636766 - Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque N/A
Recruiting NCT06166121 - Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules N/A
Withdrawn NCT03382249 - Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Phase 1/Phase 2
Recruiting NCT04679727 - The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
Withdrawn NCT02995642 - Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation Phase 2
Suspended NCT01000181 - Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT N/A
Completed NCT00001368 - Potential Risk Factors for Stroke Phase 1
Recruiting NCT04537403 - PET Detection of CCR2 in Human Atherosclerosis Phase 1
Recruiting NCT05800821 - Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
Completed NCT00147251 - Stop Atherosclerosis in Native Diabetics Study Phase 4
Completed NCT00147797 - Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy N/A
Completed NCT00180518 - ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" Phase 2/Phase 3
Completed NCT05230576 - Intelligent Detection of Carotid Plaque and Its Stability Based on Deep Learning Dynamic Ultrasound Scanning
Terminated NCT03764306 - New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis N/A